Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Running Your Business

Actavis loses ruling on immediate-release Alzheimer’s drug

By Edvard Pettersson

X
Your article was successfully shared with the contacts you provided.

(Bloomberg) — Actavis P.L.C. was ordered to continue to provide the immediate-release version of its Namenda Alzheimer’s drug in a win for New York Attorney General Eric Schneiderman, who sued the company in September.

The Dublin-based company confirmed in a statement today that U.S. District Judge Robert Sweet in Manhattan intends to issue a preliminary injunction in the antitrust case requiring it to continue distributing the immediate-release tablets. The ruling was filed under seal.

Schneiderman sued Actavis Sept. 15, alleging the drugmaker was “gaming” the system by discontinuing the immediate-release drug, which is facing competition from generic versions as the patent expires next year, and forcing patients to switch to the extended-release drug, which has longer-running patents.

“Today’s decision prevents Actavis from pursuing its scheme to block competition and maintain its high drug prices,” Schneiderman said in a statement. “Our lawsuit against Actavis sends a clear message: Drug companies cannot illegally prioritize profits over patients.”

Actavis said that the judge has set a hearing for Dec. 15 on the scope of the injunction and that it will immediately appeal the decision.

The case is People v. Actavis Plc, 14-cv-07473, U.S. District Court, Southern District of New York (Manhattan).

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.